Nuwellis

NUWE · NASDAQ

$0.5495−$0.0085 (−1.52%)TodayMarket closed ·
Prev close $0.558

Latest news

  • Press releaseGlobe Newswire

    Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs

  • News

    Nuwellis Q2 2026 Earnings Call Transcript

  • Press releaseGlobe Newswire

    Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

  • Press releaseGlobe Newswire

    Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

  • Press releaseGlobe Newswire

    Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Surges 300 Points; Amazon Shares Jump Following Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsHenry Khederian

    Nuwellis Stock Explodes Thursday: What's Driving the Action?

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsMohd Haider

    Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Crude Oil Down 4%; Paychex Posts Upbeat Earnings

  • NewsAvi Kapoor

    Nasdaq Gains Over 100 Points; US Current Account Deficit Widens In Q1

  • Press releaseGlobe Newswire

    Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

  • News

    Nuwellis Q1 2026 Earnings Call Transcript

  • Press releaseGlobe Newswire

    Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    Benzinga Bulls And Bears: Microsoft, Meta, UnitedHealth — And Warsh Pick Jolts Markets

  • NewsSurbhi Jain

    Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

  • NewsAvi Kapoor

    Dow Falls Over 300 Points; General Motors Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releaseGlobe Newswire

    Nuwellis, Inc. Participates in a Virtual Investor "What This Means" Segment

  • Press releaseGlobe Newswire

    Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsAvi Kapoor

    Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings

  • NewsAvi Kapoor

    US Stocks Mixed; Bank of America Earnings Top Views

  • News

    Market-Moving News for July 16th

  • NewsRishabh Mishra

    US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus

  • NewsMohd Haider

    Nuwellis Soars 31.25% In After-Hours Trading — What's Behind The Surge?

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.